US OptionsDetailed Quotes

NVO241213P118000

Watchlist

12.48
-5.54-30.74%

15min DelayClose Dec 13 16:00 ET

12.48High12.48Low

Novo-Nordisk A/S Stock Discussion

Money Thrill

Yesterday 00:06

European News. EMA, positive on reduction Kidney disease for LABEL EXTENSION

$Novo-Nordisk A/S (NVO.US)$ European Medicines Agency (EMA) has adopted a positive opinion for an update of the label of Ozempic ® (once-weekly subcutaneous semaglutide) to reflect data from the FLOW trial on renal outcomes.
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...

pootpoot

Dec 11 11:38

$Novo-Nordisk A/S (NVO.US)$ when semicons are bad and you want to strangle someone...

Share Your Profit/Loss

Money Thrill

Dec 9 02:50

European Morning News, Green light from Brussels ( CercleFinance)

$Novo-Nordisk A/S (NVO.US)$ announces that the European Commission has approved the acquisition by Novo Holdings of Catalent, an American contract development and manufacturing company, as well as the subsequent purchase by Novo Nordisk of three factories from NovoHoldings.
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...

Yolion

Dec 8 08:22

$Novo-Nordisk A/S (NVO.US)$

Ultratech

Dec 7 06:37

$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly

pootpoot

Dec 6 09:48

$Novo-Nordisk A/S (NVO.US)$
it's so greeen

Khaliq88

Dec 6 01:32

$Novo-Nordisk A/S (NVO.US)$

JamesChen12

Dec 5 22:29

$Novo-Nordisk A/S (NVO.US)$ I HATE THIS STOCK WITH A BURNING PASSION WHO EVER MADE THIS STOCK SHOULD BE LOCKED UP I HATE U

Stock_Drift

Dec 4 04:15

$Novavax (NVAX.US)$ $Novo-Nordisk A/S (NVO.US)$

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million

Money Thrill

Dec 3 08:53

European News. Novo will present its advances in hematology [CercleFinance]

$Novo-Nordisk A/S (NVO.US)$ announces the presentation of 13 abstracts, during the 66th Annual Meeting of the American Society of Hematology (ASH) which will take place will be held in San Diego December 7-10, 2024. Presentations include 52-week results from the phase HIBISCUS trial 2/3 on etavopivat will be presented on December 7, highlighting its effectiveness and safety for the treatment of sickle cell disease.
Add...

No comment yet